Further research by Turner et al. showed that a potential resistance mechanism to CDK4/6 treatment—and thus leading to tumour relapse—might involve specific mutations occurring in Rb, ERS1, and PIK3 CA genes [19]. The gene discussed is CDK4; the disease is neoplasm.